The present invention discloses an intelligent, bioengineered
wound dressing device that utilizes
honey bee-derived therapeutic compounds integrated into a programmable, multi-layered delivery structure designed for sustained
antimicrobial release and dynamic
wound healing modulation. The device features microencapsulated honey,
propolis, and
beeswax components embedded within a biocompatible
hydrogel matrix, supported by a control technique that processes real-time wound data acquired through embedded biosensors. The technique classifies healing phases, detects wound anomalies, and modulates therapeutic release through actuators based on environmental cues such as pH, temperature, and
exudate levels. The
system further includes a
logic control unit capable of
adaptive learning,
remote data transmission, and wound trajectory
logging, ensuring precise, patient-specific therapeutic delivery. By integrating natural
antimicrobial agents with intelligent sensing and release architectures, the invention provides a responsive, self-optimizing
wound care platform that enhances healing outcomes, reduces dressing intervention frequency, and improves clinical oversight through real-time therapeutic intelligence.